Regulation of transforming growth factor β1 by radiation in cells of two human breast cancer cell lines

Radiation Research

Volumn 152, Issue 5, 1999, Pages 487-492

  Arnold, Steven F ^a   Tims, Erin ^a   Bluman, Eric M ^a   McGrath, Brian E ^a  

^a BUFFALO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL COUNT; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

BASE SEQUENCE; BREAST NEOPLASMS; CELL DIVISION; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS; STAPHYLOCOCCUS PHAGE 3A; TRIXIS;

EID: 0032717950     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3580144     Document Type: Article

References (30)

1. B. A. Arrick, M. Korc and R. Derynck, Differential regulation of expression of three transforming growth factor β species in human breast cancer cells by estradiol. Cancer Res. 50, 299-303 (1990).
2. S. P. Zhou, P. Buckhaults, L. Zawel, F. Bunz, G. Riggins, J. L. Dai, S. E. Kem, K. W. Kinzler and B. Vogelstein, Targeted deletion of Smad4 shows it is required for transforming growth factor and activin signaling in colorectal cancer cells. Proc. Natl. Acad. Sci. USA 95, 2412-2416 (1998).
3. M. Reiss and M. H. Barcellos-Hoff, The role of transforming growth factor-β in breast cancer: A working hypothesis. Br. Cancer Res. Treat. 45, 81-95 (1997).
4. L. Sun and C. Chen, Expression of transforming growth factor-β type III receptor suppresses tumorigenicity of human breast cancer MDA-MB-231 cells. J. Biol. Chem. 272, 25367-25372 (1997).
5. C. Chen, X-F. Wang and L. Sun, Expression of transforming growth factor beta (TGFβ) type III receptor restores autocrine TGFβ1 activity in human breast cancer MCF-7 cells. J. Biol. Chem. 272, 12862-12867 (1997).
6. C. Knabbe, M. E. Lippman, L. M. Wakefield, K. C. Flanders, A. Kasid, R. Derynck and R. B. Dickson, Evidence that transforming growth factor is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48, 417-428 (1987).
7. D. R. Welch, A. Fabra and M. Nakajima, Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc. Natl. Acad. Sci. USA 87, 7678-7682 (1990).
8. J. S. Munger, J. G. Harpel, P. E. Gleizes, R. Mazzieri, I. Nunes and D. B. Rifkin, Latent transforming growth factor-beta: Structural features and mechanisms of activation. Kidney Int. 51, 1376-1382 (1997).
9. E. J. Ehrhart, P. Segarini, M. L. Tsang, A. G. Carroll and M. H. Barcellos-Hoff, Latent transforming growth beta 1 activation in situ: Quantitative and functional evidence after low-dose gamma-irradiation. FASEB J. 11, 991-1002 (1997).
10. M. H. Barcellos-Hoff and T. A. Dix, Redox-mediated activation of latent transforming growth factor-beta 1. Mol. Endocrinol. 10, 1077-1083 (1996).
11. R-M. Lyons, J. Keski-Oja and H. L. Moses, Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J. Cell. Biol. 106, 1659-1665 (1988).
12. M. J. Oursler, B. L. Riggs and T. C. Spelsberg, Glucocorticoid-induced activation of latent transforming growth factor-beta by normal human osteoblast-like cells. Endocrinology 133, 2187-2196 (1993).
13. S. Schultz, S. Ribeiro, L. Gentry and J. E. Murphy-Ullrich, Thrombospondin binds and activates the small and large forms of latent transforming growth factor beta in a chemically defined system. J. Biol. Chem. 269, 26775-26782 (1994).
14. S. E. Crawford, V. Stellmach, J. E. Murphy-Ullrich, S. M. Ribeiro, J. Lawler, R. O. Hynes, G. P. Boivin and N. Bouck, Thrombospondin-1 is a major activator of TGF betal in vivo. Cell 93, 1159-1170 (1998).
15. M. H. Barcellos-Hoff, R. Derynck, L-S. Tsang and J. A. Weatherbee, Transforming growth factor activation in irradiated murine mammary gland. J. Clin. Invest. 93, 892-899 (1994).
16. M. H. Barcellos-Hoff, Radiation-induced transforming growth factor beta and subsequent extracellular matrix reorganization in murine mammary gland. Cancer Res. 53, 3880-3886 (1993).
17. H. S. Lee, F. Kooshesh, D. N. Sauder and S. Kondo, Modulation of TGF-beta 1 production from human keratinocytes by UVB. Exp. Dermatol. 6, 105-110 (1997).
18. M. Martin, M. C. Vozenin, N. Gault, F. Crechet, C. M. Pfarr and J. L. Lefaix, Coactivation of AP-1 activity and TGF-beta1 gene expression in the stress response of normal skin cells to ionizing radiation. Oncogene 15, 981-989 (1997).
19. J. Carmichael, W. G. DeGraff, A. F. Gazdar, J. D. Minna and J. B. Mitchell, Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res. 47, 936-942 (1987).
20. R. Hardmeier, H. Hoeger, S. Fang-Kircher, A. Khoschsorur and G. Lubec, Transcription and activity of antioxidant enzymes after ionizing irradiation in radiation-resistant and radiation-sensitive mice. Proc. Natl. Acad. Sci. USA 94, 7572-7576 (1997).
21. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371, 257-261 (1994).
22. S. Tanaka and J. R. Wands, Insulin receptor substrate I overexpression in human hepatocellular carcinoma cells prevents transforming growth factor β1-induced apoptosis. Cancer Res. 56, 3391-3394 (1996).
23. Y. Oh, H. L. Muller, L. Ng and R. G. Rosenfeld, Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth binding protein-3 action. J. Biol. Chem. 270, 13589-13592 (1995).
24. R. Rajah, B. Valentinis and P. Cohen, Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism. J. Biol. Chem. 272, 12181-12182 (1997).
25. J. Kleeff and M. Korc, Up-regulation of transforming growth factor (TGF)-β receptors by TGF-β1 in COLO-357 cells. J. Biol. Chem. 273, 7495-7500 (1998).
26. M. Villalobos, D. Becerra, M. I. Nunez, M. T. Valenzuela, E. Siles, N. Olea, V. Pedraza and J. M. Ruiz de Almodovar, Radiosensitivity of human breast cancer cell lines of different hormonal responsiveness. Modulatory effects of oestradiol. Int. J. Radiat. Biol. 70, 161-169 (1996).
27. G. H. Paulsen, T. Strickert, A-B. Marthinsen and S. Lundgren, Changes in radiation sensitivity and steroid receptor content induced by hormonal agents and ionizing radiation in breast cancer cells in vitro. Acta Oncol. 35, 1011-1019 (1996).
28. M. Villalobos, M. Aranda, M. I. Nunez, D. Becerra, N. Olea, J. M. Ruiz de Almodovar and V. Pedraza, Interaction between ionizing radiation, estrogens and antiestrogens in the modification of tumor microenvironment in estrogen dependent multicellular spheroids. Acta Oncol. 34, 413-417 (1995).
29. J. N. Sarkaria, E. M. Miller, C. J. Parker, V. C. Jordan and R. T. Mulcahy, 4-Hydroxytamoxifen, an active metabolite of tamoxifen, does not alter the radiation sensitivity of MCF-7 breast carcinoma cells irradiated in vitro. Breast Cancer Res. Treat. 30, 159-165 (1994).
30. D. A. Kantorowitz, H. J. Thompson and P. Furmanski, Effect of conjoint administration of tamoxifen and high-dose radiation on the development of mammary carcinoma. Int. J Radiat. Oncol. Biol. Phys. 26, 89-94 (1993).